Figure 8From: Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivoeffects on migration capacity and tumor growth Migration-related gene expression by quantitative (PCR). CXCR4, CXCL12, CCL5, CCL2, and MMP-2 expression in tumors (control group) was compared with expression in tumors consisting of HeLa cells and mesenchymal stem cells (MSCs) or of HeLa cells and human induced pluripotent stem cells (hiPSCs) (analyzed 24 days after stem cell injection). The ratio of the fold difference expression for each gene to 18S was calculated by using the -ΔΔCq formula. Expression obtained from the control group was used as a calibrator.Back to article page